Table of Contents

Executive Summary

1 Industry Overview of Dementia Drugs

• 1.1 Definition of Dementia Drugs
• 1.2 Dementia Drugs Segment by Type
  • 1.2.1 Global Dementia Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 MAO Inhibitors
  • 1.2.3 Cholinesterase Inhibitors
  • 1.2.4 Glutamate Inhibitors
• 1.3 Dementia Drugs Segment by Applications
  • 1.3.1 Global Dementia Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail Pharmacies
  • 1.3.4 Others
• 1.4 Global Dementia Drugs Overall Market
  • 1.4.1 Global Dementia Drugs Revenue (2014-2025)
  • 1.4.2 Global Dementia Drugs Production (2014-2025)
  • 1.4.3 North America Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Dementia Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Dementia Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Dementia Drugs
• 2.3 Manufacturing Process Analysis of Dementia Drugs
• 2.4 Industry Chain Structure of Dementia Drugs

3 Development and Manufacturing Plants Analysis of Dementia Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Dementia Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Dementia Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Dementia Drugs Production and Capacity Analysis
• 4.2 Dementia Drugs Revenue Analysis
• 4.3 Dementia Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Dementia Drugs Regional Market Analysis

• 5.1 Dementia Drugs Production by Regions
  • 5.1.1 Global Dementia Drugs Production by Regions
  • 5.1.2 Global Dementia Drugs Revenue by Regions
• 5.2 Dementia Drugs Consumption by Regions
• 5.3 North America Dementia Drugs Market Analysis
  • 5.3.1 North America Dementia Drugs Production
  • 5.3.2 North America Dementia Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Dementia Drugs Import and Export
• 5.4 Europe Dementia Drugs Market Analysis
  • 5.4.1 Europe Dementia Drugs Production
  • 5.4.2 Europe Dementia Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Dementia Drugs Import and Export
• 5.5 China Dementia Drugs Market Analysis
  • 5.5.1 China Dementia Drugs Production
  • 5.5.2 China Dementia Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Dementia Drugs Import and Export
• 5.6 Japan Dementia Drugs Market Analysis
  • 5.6.1 Japan Dementia Drugs Production
  • 5.6.2 Japan Dementia Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Dementia Drugs Import and Export
• 5.7 Southeast Asia Dementia Drugs Market Analysis
  • 5.7.1 Southeast Asia Dementia Drugs Production
  • 5.7.2 Southeast Asia Dementia Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Dementia Drugs Import and Export
• 5.8 India Dementia Drugs Market Analysis
  • 5.8.1 India Dementia Drugs Production
  • 5.8.2 India Dementia Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Dementia Drugs Import and Export

6 Dementia Drugs Segment Market Analysis (by Type)

• 6.1 Global Dementia Drugs Production by Type
• 6.2 Global Dementia Drugs Revenue by Type
• 6.3 Dementia Drugs Price by Type

7 Dementia Drugs Segment Market Analysis (by Application)

• 7.1 Global Dementia Drugs Consumption by Application
• 7.2 Global Dementia Drugs Consumption Market Share by Application (2014-2019)

8 Dementia Drugs Major Manufacturers Analysis

• 8.1 Eisai, Inc
  • 8.1.1 Eisai, Inc Dementia Drugs Production Sites and Area Served
  • 8.1.2 Eisai, Inc Product Introduction, Application and Specification
  • 8.1.3 Eisai, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Janssen Pharmaceuticals, Inc
  • 8.2.1 Janssen Pharmaceuticals, Inc Dementia Drugs Production Sites and Area Served
  • 8.2.2 Janssen Pharmaceuticals, Inc Product Introduction, Application and Specification
  • 8.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Biogen Pharmaceuticals
  • 8.3.1 Biogen Pharmaceuticals Dementia Drugs Production Sites and Area Served
  • 8.3.2 Biogen Pharmaceuticals Product Introduction, Application and Specification
  • 8.3.3 Biogen Pharmaceuticals Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Forest Laboratories, Inc
  • 8.4.1 Forest Laboratories, Inc Dementia Drugs Production Sites and Area Served
  • 8.4.2 Forest Laboratories, Inc Product Introduction, Application and Specification
  • 8.4.3 Forest Laboratories, Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Eli Lilly and Company
  • 8.5.1 Eli Lilly and Company Dementia Drugs Production Sites and Area Served
  • 8.5.2 Eli Lilly and Company Product Introduction, Application and Specification
  • 8.5.3 Eli Lilly and Company Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Novartis AG
  • 8.6.1 Novartis AG Dementia Drugs Production Sites and Area Served
  • 8.6.2 Novartis AG Product Introduction, Application and Specification
  • 8.6.3 Novartis AG Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Sanofi S.A
  • 8.7.1 Sanofi S.A Dementia Drugs Production Sites and Area Served
  • 8.7.2 Sanofi S.A Product Introduction, Application and Specification
  • 8.7.3 Sanofi S.A Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 AstraZeneca GmbH
  • 8.8.1 AstraZeneca GmbH Dementia Drugs Production Sites and Area Served
  • 8.8.2 AstraZeneca GmbH Product Introduction, Application and Specification
  • 8.8.3 AstraZeneca GmbH Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 F. Hoffmann-La Roche
  • 8.9.1 F. Hoffmann-La Roche Dementia Drugs Production Sites and Area Served
  • 8.9.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
  • 8.9.3 F. Hoffmann-La Roche Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Merck & Co., Inc
  • 8.10.1 Merck & Co., Inc Dementia Drugs Production Sites and Area Served
  • 8.10.2 Merck & Co., Inc Product Introduction, Application and Specification
  • 8.10.3 Merck & Co., Inc Dementia Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Valeant Pharmaceutical International
• 8.12 Pfizer Inc
• 8.13 Teva Pharmaceuticals Industries

9 Development Trend of Analysis of Dementia Drugs Market

• 9.1 Global Dementia Drugs Market Trend Analysis
  • 9.1.1 Global Dementia Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Dementia Drugs Regional Market Trend
  • 9.2.1 North America Dementia Drugs Forecast 2019-2025
  • 9.2.2 Europe Dementia Drugs Forecast 2019-2025
  • 9.2.3 China Dementia Drugs Forecast 2019-2025
  • 9.2.4 Japan Dementia Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Dementia Drugs Forecast 2019-2025
  • 9.2.6 India Dementia Drugs Forecast 2019-2025
• 9.3 Dementia Drugs Market Trend (Product Type)
• 9.4 Dementia Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Dementia Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

The global Dementia Drugs market was valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025.
This report focuses on Dementia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dementia Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dementia Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dementia Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Eisai, Inc
Janssen Pharmaceuticals, Inc
Biogen Pharmaceuticals
Forest Laboratories, Inc
Eli Lilly and Company
Novartis AG
Sanofi S.A
AstraZeneca GmbH
F. Hoffmann-La Roche
Merck & Co., Inc
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
MAO Inhibitors
Cholinesterase Inhibitors
Glutamate Inhibitors

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others